|
IPP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.76778600039052E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.61484192473927E-12 |
| Normal-vs-Stage2 |
1.954890E-04 |
| Normal-vs-Stage3 |
3.76130000000474E-05 |
| Normal-vs-Stage4 |
1.02810004953824E-09 |
| Stage1-vs-Stage2 |
7.944200E-01 |
| Stage1-vs-Stage3 |
8.313600E-01 |
| Stage1-vs-Stage4 |
5.240000E-02 |
| Stage2-vs-Stage3 |
9.454400E-01 |
| Stage2-vs-Stage4 |
1.427820E-01 |
| Stage3-vs-Stage4 |
8.631600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.76581013436817E-12 |
| Normal-vs-AfricanAmerican |
5.34261523910118E-12 |
| Normal-vs-Asian |
4.246100E-02 |
| Caucasian-vs-AfricanAmerican |
2.289000E-01 |
| Caucasian-vs-Asian |
6.818800E-01 |
| AfricanAmerican-vs-Asian |
9.463400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.54321000422897E-14 |
| Normal-vs-Female |
3.209900E-04 |
| Male-vs-Female |
1.804280E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.20039999951649E-07 |
| Normal-vs-Extreme_Weight |
1.66111568944416E-12 |
| Normal-vs-Obese |
2.46019999927682E-08 |
| Normal-vs-Extreme_Obese |
4.898800E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.259000E-01 |
| Normal_Weight-vs-Obese |
7.449800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.624200E-01 |
| Extreme_Weight-vs-Obese |
7.566200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.016800E-01 |
| Obese-vs-Extreme_Obese |
8.014400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.840800E-04 |
| Normal-vs-Age(41-60Yrs) |
7.99449950683595E-10 |
| Normal-vs-Age(61-80Yrs) |
2.02671213145322E-12 |
| Normal-vs-Age(81-100Yrs) |
5.15829999825357E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.749600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.065600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.784600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.616770E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.148200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.351800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.96509475358653E-13 |
| Normal-VS-Type2 PRCC |
1.06600000049362E-07 |
| Normal-VS-KIRP CIMP |
8.240100E-03 |
| Normal-VS-Unclassified PRCC |
2.590800E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.910200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.565600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.198050E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.537800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.825200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.141000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.69984076498531E-12 |
| Normal-vs-N1 |
6.175700E-04 |
| Normal-vs-N2 |
1.378340E-04 |
| N0-vs-N1 |
1.993150E-01 |
| N0-vs-N2 |
8.682400E-01 |
| N1-vs-N2 |
5.177400E-01 |
|
|
